Key result
Late-detected coarctation of the aorta presents with resistant hypertension that remains difficult to control on mono or dual pharmacotherapy even after successful surgical treatment.
Highlights the critical need for lifelong follow-up and aggressive hypertension management in patients with late-detected coarctation of the aorta, even post-surgery.
Supports lifelong BP surveillance after late coarctation repair; leaves open optimal regimens for resistant hypertension.
Coarctation of the aorta (CoA) is a common Congenital Heart Disease (CHD) presenting with many symptoms and signs, in any age group. From its dramatic appearance as a part of Hypo plastic Left Heart Syndrome(HLHS), to early Congestive Heart Failure(CHF)in neonatal and early infantile age, to undetected Hypertension (HTN) in early or even late adulthood. The aim of this short review is to present this unique CHD, underline the presentation of late detected CoA, presenting with HTN and its impact in treating resistant HTN even after successful surgical treatment. Finally, the late onset HTN, following successful surgical treatment and its medicine management will be addressed. This diffi cult to control on mono or dual pharmacotherapy and the late complications of persistent uncontrolled HTN is the basic reason that these patients are a long-life follow-up population with important medical needs and increasing morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Saad et al. (2017) conducted a review in Coarctation of the aorta. Late-detected coarctation of the aorta was evaluated. Late-detected coarctation of the aorta presents with resistant hypertension that remains difficult to control on mono or dual pharmacotherapy even after successful surgical treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: